The quarter beat the company’s own operating target, but there is no published consensus in the filing to establish a broader analyst beat. Estimated Standalone Adjusted EBITDA came in at $41.8 million, above the previous $37 million–$41 million range, while sales reached $245.4 million. That makes the cleanest benchmark a narrow beat against prior guidance, not a proven consensus surprise. (Second Quarter 2026 Highlights; Guidance)
| Metric | Q2 2026 | Prior-year period / prior guide | Read |
|---|---|---|---|
| Net sales | $245.4M | $216.7M | +13.2% reported, but only +1.2% organically (Condensed Combined Statements of Earnings; Reconciliation of Change in Net Sales) |
| Net earnings | $10.8M | $29.1M | Down sharply year over year (Condensed Combined Statements of Earnings) |
| Adjusted EBITDA | $42.3M | $39.1M | +8.2% year over year (Reconciliation of Net Earnings to Adjusted EBITDA) |
| Estimated Standalone Adjusted EBITDA | $41.8M | $37.8M; prior guide $37M–$41M | Above the prior guide’s high end (Second Quarter 2026 Financial Results; Reconciliation of Net Earnings to Adjusted EBITDA) |
| Orders | $275M | Prior-year orders implied by +16% growth | Demand indicator improved materially (Second Quarter 2026 Highlights) |
| Backlog | $446M | Record level | Supports near-term visibility, though conversion timing remains uncertain (Second Quarter 2026 Highlights) |
The headline growth is acquisition-led rather than broadly organic. Of the $28.7 million year-over-year sales increase, $23.9 million came from the Frigomeccanica and Oka acquisitions; organic sales growth was only 1.2%, with delayed snack-equipment shipments partly offsetting stronger aftermarket activity. The 13.2% reported sales increase therefore overstates the underlying demand improvement. (Second Quarter 2026 Financial Results)
Profitability improved on the company’s preferred metric, while GAAP earnings deteriorated. Estimated Standalone Adjusted EBITDA rose 10.6% year over year and its margin was 17.0%, but net earnings fell to $10.8 million from $29.1 million. The gap reflects higher taxes, other expense, and $10.4 million of separation costs; the result is a meaningful reminder that the first standalone quarter carries substantial reporting and public-company friction. (Condensed Combined Statements of Earnings; Reconciliation of Net Earnings to Adjusted EBITDA)
The full-year raise is modest but directionally better than the prior setup. The sales midpoint increased from $930 million to $950 million, while the Estimated Standalone Adjusted EBITDA midpoint moved from $165 million to $168 million. The updated midpoint implies roughly 11% sales growth, 6% organic sales growth, and 20% EBITDA growth versus fiscal 2025. The raise is supportive, but the small EBITDA midpoint increase and low current-quarter organic growth leave execution—not the headline acquisition contribution—as the key issue. (Guidance)
The balance sheet leaves room for acquisitions and shareholder dilution management. Net debt was $208.1 million, equal to 1.3x last-twelve-month Estimated Standalone Adjusted EBITDA, with $822.5 million of total liquidity. The newly authorized $50 million repurchase program is primarily intended to offset equity-award dilution, not a committed return of excess capital. (Financial Position; Net Debt and Net Leverage Ratio; Share Repurchase Program)
Read the original 8-K on SEC EDGAR ↗